Purchase Articles

Showing 49–64 of 138 results

• 

  Clinical Trials in Canada: Worrying Signs that PMPRB Changes will Impact Research Investment

  $20.00 Add to cart
• 

  Essais cliniques au Canada: des signes inquiétants que l’incertitude liée aux changements du CEPMB affectera les investissements en recherche

  $20.00 Add to cart
• 

  Patented Medicines Expenditure in Canada 1990-2018

  $0.00 Add to cart
• 

  Canada’s Vaccine Development Capacity and the Federal Government’s Management of COVID-19

  $0.00 Add to cart
• 

  E-Mental Health Services and Unmet Needs of Canadians

  $20.00 Add to cart
• 

  Universal public funding for dental care in Canada: problems, policies, and politics.

  $20.00 Add to cart
• 

  Ensuring early access to a COVID-19 vaccine in Canada

  $0.00 Add to cart
• 

  Vaccines policy in Canada: International and Domestic Comparisons.

  $0.00 Add to cart
• 

  Career Options and Professional Integration of Internationally Trained Physicians in Canada.

  $20.00 Add to cart
• 

  Evidence that regulating pharmaceutical prices negatively affects R&D and access to new medicines.

  $0.00 Add to cart
• 

  COVID-19 Economic Costs and the Implicit Value of a Life-Year in Canada

  $0.00 Add to cart
• 

  Did the PMPRB censor CHPI’s Submission to its Draft Guidelines Consultation?

  $0.00 Add to cart
• 

  Clinical Trials in Canada Decrease: A Sign of Uncertainty Regarding Changes to the PMPRB?

  $20.00 Add to cart
• 

  A Socio-Psychological Perspective on Flattening the COVID-19 Curve.

  $20.00 Add to cart
• 

  Patented Medicines Costs of Private Insurers: PMPRB Implications.

  $0.00 Add to cart
• 

  Fewer new drug approvals in Canada: early indication of unintended consequences from new PMPRB regs?

  $20.00 Add to cart